Agency recommends moving away from testing each individual donation to testing pooled donations
MONDAY, July 9, 2018 (HealthDay News) — Individual blood donations will no longer need to be tested for the Zika virus, according to the U.S. Food and Drug Administration.
“When Zika virus first emerged, the unknown course of the epidemic and the observed severe effects from the disease indicated that individual donor testing was needed to ensure the continued safety of the blood supply,” Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, explained in an agency press release. “Now, given the significant decrease in cases of Zika virus infection in the United States and its territories, we are moving away from testing each individual donation to testing pooled donations.”
Pooled testing of donations is considered less burdensome and more cost-effective for blood establishments. However, the FDA will continue to monitor the situation closely, and if necessary, reconsider what measures are needed to maintain the safety of the blood supply.
Bacterial Vaginosis Linked to Tripled Odds of STI Coinfection 
AI Can Accurately Detect Left Ventricular Dysfunction From Electrocardiograms 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
Female Emergency Medicine Physicians Order More Tests, Admit More Patients .jpg)
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest 
Barriers to Pediatric Cancer Clinical Trial Participation Identified 
Protocol IDs Patients Who Can Be Treated While Seated in the ED 
Emergency Presentation of Cancer Common in Older Adults 
